These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27358753)

  • 1. Tissue barriers and novel approaches to achieve hepatoselectivity of subcutaneously-injected insulin therapeutics.
    Shao J; Zaro JL; Shen WC
    Tissue Barriers; 2016; 4(2):e1156804. PubMed ID: 27358753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel hepatoselective insulin analog: studies with a covalently linked thyroxyl-insulin complex in humans.
    Shojaee-Moradie F; Powrie JK; Sundermann E; Spring MW; Schüttler A; Sönksen PH; Brandenburg D; Jones RH
    Diabetes Care; 2000 Aug; 23(8):1124-9. PubMed ID: 10937509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinsulin-Transferrin Fusion Protein Exhibits a Prolonged and Selective Effect on the Control of Hepatic Glucose Production in an Experimental Model of Type 1 Diabetes.
    Shao J; Zaro JL; Shen WC
    Mol Pharm; 2016 Aug; 13(8):2641-6. PubMed ID: 27280852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatoselectivity and the evolution of insulin.
    Herring R; Jones RH; Russell-Jones DL
    Diabetes Obes Metab; 2014 Jan; 16(1):1-8. PubMed ID: 23679086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel hepatoselective insulin analogues: studies with covalently linked thyroxyl-insulin complexes.
    Shojaee-Moradie F; Eckey H; Jackson NC; Schüttler A; Brandenburg D; Sönksen PH; Jones RH
    Diabet Med; 1998 Nov; 15(11):928-36. PubMed ID: 9827847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution, activation, and retention of proinsulin-transferrin fusion protein in the liver: Mechanism of liver-targeting as an insulin prodrug.
    Liu Y; Wang HY; Zhou L; Su Y; Shen WC
    J Control Release; 2018 Apr; 275():186-191. PubMed ID: 29471040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proinsulin-transferrin fusion protein as a novel long-acting insulin analog for the inhibition of hepatic glucose production.
    Wang Y; Shao J; Zaro JL; Shen WC
    Diabetes; 2014 May; 63(5):1779-88. PubMed ID: 24353179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-derived amyloidosis without a palpable mass at the insulin injection site: A report of two cases.
    Nagase T; Iwaya K; Kogure K; Zako T; Misumi Y; Kikuchi M; Matsumoto K; Noritake M; Kawachi Y; Kobayashi M; Ando Y; Katsura Y
    J Diabetes Investig; 2020 Jul; 11(4):1002-1005. PubMed ID: 31867887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover study.
    Cernea S; Kidron M; Wohlgelernter J; Raz I
    Clin Ther; 2005 Oct; 27(10):1562-70. PubMed ID: 16330292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes?
    Maiorino MI; Petrizzo M; Capuano A; Giugliano D; Esposito K
    Expert Opin Biol Ther; 2014 Jun; 14(6):799-808. PubMed ID: 24673155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating advances in insulin into clinical practice: Advances In insulin formulations.
    King A
    J Fam Pract; 2013 Sep; 62(9 Suppl Insulin):S9-17. PubMed ID: 24080573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal or subcutaneous insulin infusion: efficacy and impact on liver inflammation.
    Dal S; Jeandidier N; Schaschkow A; Spizzo AH; Seyfritz E; Sookhareea C; Bietiger W; Péronet C; Moreau F; Pinget M; Maillard E; Sigrist S
    Fundam Clin Pharmacol; 2015 Oct; 29(5):488-98. PubMed ID: 26095147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating advances in insulin into clinical practice: Overview of current insulin formulations.
    Rhinehart AS
    J Fam Pract; 2013 Sep; 62(9 Suppl Insulin):S4-8. PubMed ID: 24080572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin administered by needle-free jet injection corrects marked hyperglycaemia faster in overweight or obese patients with diabetes.
    de Wit HM; Engwerda EE; Tack CJ; de Galan BE
    Diabetes Obes Metab; 2015 Nov; 17(11):1093-9. PubMed ID: 26259978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin signaling in the liver and uterus of ovariectomized rats treated with estradiol.
    Koricanac G; Milosavljevic T; Stojiljkovic M; Zakula Z; Ribarac-Stepic N; Isenovic ER
    J Steroid Biochem Mol Biol; 2008 Jan; 108(1-2):109-16. PubMed ID: 17931855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical strategies for controlling peaks and valleys: type 1 diabetes.
    Bolli GB
    Int J Clin Pract Suppl; 2002 Jul; (129):65-74. PubMed ID: 12166610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and variability of biphasic insulin mixtures.
    Søeborg T; Rasmussen CH; Mosekilde E; Colding-Jørgensen M
    Eur J Pharm Sci; 2012 Jul; 46(4):198-208. PubMed ID: 21703346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel and Emerging Insulin Preparations for Type 2 Diabetes.
    Cheung KK; Alexander P
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S160-6. PubMed ID: 26653255
    [No Abstract]   [Full Text] [Related]  

  • 20. Basal insulins: Pharmacological properties and patient perspectives.
    Abrahamson MJ
    Prim Care Diabetes; 2010 Apr; 4 Suppl 1():S19-23. PubMed ID: 20394887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.